 |
|
|
 |
|
Scientists Spot Key Autoimmune Disease Genes
Discovery could unlock secrets to lupus, rheumatoid arthritis, even cancer, experts say
By Jeffrey Perkel HealthDay Reporter
|
 |  |  |  | Related Healthscout Videos |  |
|
MONDAY, Jan. 22 (HealthDay News) -- The identification by U.S. scientists of genes thought to be key to autoimmune disorders could be a big step toward new treatments for these illnesses, which include lupus, rheumatoid arthritis and type 1 diabetes.
Cells called regulatory T-cells are supposed to help keep the immune system in check, but in autoimmune disease, these mechanisms can fail.
Text Continues Below

Now, researchers reporting this week in the journal Nature have identified a set of genes closely linked to regulatory T-cell function. The finding could have important implications for research into autoimmune disease and even cancer, experts say.
"This is certainly important in trying to understand how these regulatory T-cells work," said Dr. Noel Rose, director of the Johns Hopkins Center for Autoimmune Disease Research in Baltimore. "Whether this will have important functional implications, only time will tell," said Rose, who was not involved in the study.
Though it is meant to shield our bodies from all pathogens foreign and domestic, the immune system can be frustratingly temperamental. For example, when presented with cancer, the system basically shrugs. In other cases, the cell's defense department can sometimes go into overdrive, leading to autoimmune disorders like systemic lupus erythematosus and Graves' disease, where the body attacks its own cells.
Both of these situations are linked to the immune system's fundamental purpose: to distinguish the body's own cells (and related entities) from foreign invaders. So, cancer cells are ignored by the immune system because they are determined to be the body's own cells. Autoimmune disorders arise when the immune system gets confused and attacks healthy tissues.
In this study, researchers from Harvard Medical School, the Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and the Whitehead Institute for Biomedical Research focused on genes that help direct these processes via regulatory T-cells.
Page: 1 | 2 | Next >>
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 1/22/2007
|
 |

SOURCES: Alexander Marson, graduate student, Whitehead Institute of Biomedical Research and Massachusetts Institute of Technology, Cambridge, Mass.; Noel R. Rose, M.D., Ph.D., professor, pathology and molecular microbiology and immunology, and director, Johns Hopkins Center for Autoimmune Disease Research, Baltimore, Md; Jan. 21, 2007, online edition, Nature
|